Search results
Indaptus reports positive Phase 1 trial results for cancer treatment By Investing.com
Investing.com· 17 hours agoIndaptus Therapeutics, Inc. (NASDAQ: INDP), a biotechnology firm focused on developing therapies for...
Claims of Misconduct Mar MDMA Research for PTSD
High Times· 56 minutes agoMedical research into using the psychedelic MDMA to treat post-traumatic stress disorder is being called into question following allegations that a clinical trial ...
Takeda's TAK-861 shows promise in narcolepsy trial By Investing.com
Investing.com· 17 hours agoOSAKA, Japan & CAMBRIDGE, Mass. - Takeda Pharmaceutical Company (NYSE:TAK) Limited (TSE:...
Promising Phase 2 Results For Biodexa's eRapa(TM) Indicates Hope for FAP Patients Who Otherwise Have...
Morningstar· 23 hours agoIn a clinical trial involving 30 adult patients, three groups received the same dose of the drug but with different regimens over a period ...
Ivonescimab shows promise in NSCLC Phase III trial By Investing.com
Investing.com· 5 days agoSummit Therapeutics Inc. (NASDAQ: NASDAQ:SMMT) announced that its Phase III clinical trial,...
Summit reports data from Phase III NSCLC treatment trial
Clinical Trials Arena via Yahoo Finance· 4 days agoSummit Therapeutics has revealed that its Phase III HARMONi-2 (AK112-303) clinical trial of...
Untapped opportunities: Fulfilling the promise of decentralized clinical trials
Pharmaceutical Technology via Yahoo Finance· 5 days agoDCTs and hybrid digital trials are on the rise – and are driving new complexities in clinical trial...
Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major...
Digital Journal· 7 days agoAt week 1, the mean reduction in MADRS score from baseline (exploratory endpoint) was significantly different between placebo and azetukalner 20 mg groups (4.88 vs 7.54; P ...
Merus shares hold Buy rating on strong trial results By Investing.com
Investing.com· 18 hours ago(NASDAQ:MRUS), a clinical-stage oncology company. The firm's optimism is based on the promising data...
Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers
NBC Universal via AOL· 4 days agoPfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for...